Pharmaceutical promotion may affect prescribing. To address the impact of pharmaceutical promotion, the following recommendations have been made by the Institute of Medicine:
1. Conflicts of interest and financial relationships should be disclosed by those providing education.
2. Providers should ban all pharmaceutical representatives from their office setting.
3. Drug samples should be used for patients who have the insurance to pay for them, to ensure the patient can afford the medication.
4. Providers should only accept low-value gifts, such as pens and pads of paper, from the pharmaceutical representative.
Question 2
The U.S. Food and Drug Administration regulates:
1. Prescribing of drugs by MDs and NPs
2. The official labeling for all prescription and over-the-counter drugs
3. Off-label recommendations for prescribing
4. Pharmaceutical educational offerings